Identification of target genes of the lymphoid-specific transcription factor Oct2

Immunobiology

Volumn 198, Issue 1-3, 1997, Pages 217-226

  Pfisterer, Petra ^a   Hess, Jochen ^a   Wirth, Thomas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; COMPLEMENTARY DNA; CYSTEINE; ELASTASE INHIBITOR; LEUKOCYTE ELASTASE; MEMBRANE PROTEIN; SECRETORY PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; B LYMPHOCYTE DIFFERENTIATION; GENE TARGETING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOGENETICS; LYMPHATIC SYSTEM; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0031465281     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80042-3     Document Type: Article

References (39)

1. PFISTERER, P., A. ANNWEILER, C. ULLMER, L. CORCORAN, and T. WIRTH. 1994. Differential transactivation potention of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J. 13: 1654-1663.
2. ROLINK, A., A. KUDO, H. KARASUYAMA, Y. KIKUCHI, and F. MELCHERS. 1991. Long-term proliferating early pre B cell lines and clonse with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO J. 10: 327-336.
3. AUSUBEL, F. M., R. BRENT, R. E. KINGSTON, D. D. MOORE, J. G. SEIDMAN, J. A. SMITH, and K. STRUHL. 1989. Current protocols in molecular biology, Vol. 1, John Wiley & Sons, New York, Chichester, Brisbane, Toronto, Singapore.
4. CHURCH, G. M., and W. GILBERT. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81: 1991-1995.
5. NIELSEN, P. J., O. GEORGIEV, B. LORENZ, and W. SCHAFFNER. 1996. B lymphocytes are impaired in mice lacking the transciptional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol. 26: 3214-3218.
6. KÖNIG, H., P. PFISTERER, L. CORCORAN, and T. WIRTH. 1995. Identification of CD36 as the first gene dependent on the B cell differentiation factor Oct2. Genes Dev. 9: 1598-1607.
7. STAUDT, L. M., and M. J. LENARDO. 1991. Immunoglobulin gene transcription. Annu. Rev. Immunol. 9: 373-398.
8. VERRIJZER, C. P., and P. C. VAN DER VLIET. 1993. POU domain transcription factors. Biochim. Biophys. Acta 1173: 1-21.
9. HERR, W., R. A. STURM, R. G. CLERC, L. M. CORCORAN, D. BALTIMORE, P. A. SHARP, H. A. INGRAHAM, M. G. ROSENFELD, M. FINNEY, G. RUVKUN, and H. R. HORVITZ. 1988. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2: 15313-1516.
10. ROSENFELD, M. G. 1991. POU-domain transciption factors: pou-er-ful developmental regulators. Genes Dev. 5: 897-907.
11. STURM, R. A., and W. HERR. 1988. The POU domain is a bipartite DNA-binding structure. Nature 336: 601-604.
12. VERRIJZER, C. P., M. J. ALKEMA, W. W. VAN WEPEREN, H. C. VAN LEEUWEN, M. J. J. STRATING, and P. C. VAN DER VLIET. 1992. The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J. 11: 4993-5003.
13. HERR, W., and M. CLEARY. 1995. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9: 1679-1693.
14. ZWILLING, S., H. KÖNIG, and T. WIRTH. 1995. HMG2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 14: 1198-1208.
15. PFISTERER, P., S. ZWILLING, J. HESS, and T. WIRTH. 1995. Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1. J. Biol. Chem. 270: 29870-29880.
16. WIRTH, T., P. PFISTERER, A. ANNWEILER, S. ZWILLING, and H. KÖNIG. 1995. Molecular principles of Oct2-mediated gene activation in B cells. Immunobiol. 193: 161-170.
17. SINGH, H., R. SEN, D. BALTIMORE, and P. A. SHARP. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319: 154-158.
18. STAUDT, L. M., H. SINGH, R. SEN, T. WIRTH, P. A. SHARP, and D. BALTIMORE. 1986. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature 323: 640-643.
19. STAUDT, L. M., R. G. CLERC, H. SINGH, J. H. LEBOWITZ, P. A. SHARP, and D. BALTIMORE. 1988. Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science 241: 577-580.
20. HATZOPOULOS, A. K., A. S. STOYKOVA, J. R. ERSELIUS, M. GOULDING, T. NEUMAN, and P. GRUSS. 1990. Structure and expression of the mouse Oct2a and Oct2b, two differentially spliced products of the same gene. Development 109: 349-362.
21. WIRTH, T., A. PRIESS, A. ANNWEILER, S. ZWILLING, and B. OELER. 1991. Multiple Oct2 isoforms are generated by alternative splicing. Nucl. Acids Res. 19: 43-51.
22. GSTAIGER, M., L. KNOEPFEL, O. GEORGIEV, W. SCHAFFNER, and C. M. HOVENS. 1995. A B cell coactivator of octamer-binding transcription factors. Nature 373: 360-362.
23. LUO, Y., H. FUJII, T. GERSTER, and R. G. ROEDER. 1992. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell 71: 231-241.
24. LUO, Y, and R. G. ROEDER. 1995. Cloning, functional characterization, and mechanism of action of the B cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15: 4115-4124.
25. STRUBIN, M., J. W. NEWELL, and P. MATTHIAS. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer proteins. Cell 80: 497-506.
26. ANNWEILER, A., M. MÜLLER-IMMERGLÜCK, and T. WIRTH. 1992. Oct2 transactivation from a remote enhancer position requires a B cell-restricted activity. Mol. Cell. Biol. 12: 3107-3116.
27. FELDHAUS, A. L., C. A. KLUG, K. L. ARVIN, and H. SINGH. 1993. Targeted disruption of the Oct2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element -mediated gene activation. EMBO J. 12: 2763-2772.
28. CORCORAN, L. M., M. KARVELAS, G. J. V. NOSSAL, Z.-S. YE, T. JACKS, and D. BALTIMORE. 1993. Oct2, although not required for early B cell development, is critical for later B cell maturation and for postnatal survival. Genes Dev. 7: 570-582.
29. CORCORAN, L. M., and M. KARVELAS. 1994. Oct2 is required early in T cell independent B cell activation for G1 progression and for proliferation. Immunity 1: 635-645.
30. KISTLER, B., P. PFISTERER, and T. WIRTH. 1995. Lymphoid-and myeloid-specific activity is determined by the combinatorial action of octamer and ets transcription factors. Oncogene 11: 1095-1106.
31. PFISTERER, P., H. KÖNIG, J. HESS, G. LIPOWSKY, B. HAENDLER, W.-D., SCHLEUNIG, and T. WIRTH. 1996. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells the control of Oct2. Mol. Cell. Biol. 16: 6160-6168.
32. GREENWALT, D. E., R. H. LIPSKY, C. F. OCKENHOUSE, H. IKEDA, N. N. TANDON, and G. A. JAMIESON. 1992. Membrane glycoprotein CD36: a review of its role in adherence, signal transduction, and transfusion medicine. Blood 80: 1105-1115.
33. MUROI, K., K. TOYA, R. SUZUKI, T. SUDA, S. SAKAMOTO, and Y. MIURA. 1992. Expression of CD11B, CD14 and CD36 antigens by B cell lymphoma. Br. J. Haematol. 80: 126-127.
34. ALTEVOGT, P., M. MICHAELIS, and B. KYEWSKI. 1989. Identical forms of the CD2 antigen expressed by mouse T and B lymphocytes. Eur. J. Immunol. 19: 1509-1512.
35. YAGITA, H., T. NAKAMURA, H. KARASUYAMA, and K. OKUMURA. 1989. Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells. Proc. Natl. Acad. Sci. USA 86: 645-649.
36. HAENDLER, B., J. KRÄTZSCHMAR, F. THEURING, and W.-D. SCHLEUNING. 1993. Transcipts for cysteine-rich secretory protein-1 (CRISP-1; DE/AEG) and a novel related CRISP-3 are expressed under androgen control in the mouse salivary gland. Endocrinology 133: 192-198.
37. SCHWIDETZKY, U., B. HAENDLER, and W.-D. SCHLEUNIG. 1995. Isolation and characterization of the androgen-dependent mouse cysteine-rich secretory protein-3 (CRISP-3) gene. Biochem. J. 309: 831-836.
38. FURTH, P. A., L. ST ONGE, H. BOGER, P. GRUSS, M. GOSSEN, A. KISTNER, H. BUJARD, and L. HENNIGHAUSEN. 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91: 9302-9306.
39. EWALD, D., M. LI, S. EFRAT, G. AUER, R. J. WALL, P. A. FURTH, and L. HENNIGHAUSEN. 1996. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273: 1384-1386.